The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

New research reveals insomnia's deep links to cardiovascular health, urging us to treat it as a core medical issue, not a ...

What’s confusing is that people who stop taking antidepressants can experience flu-like withdrawal symptoms as the body ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind” or the "Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...

TRICARE coverage is primarily used by active and retired military service members and their eligible family members. This policy update, effective immediately, applies to TRICARE beneficiaries in the ...

Britain’s grey skies can darken anyone’s mood, but for those who suffer with seasonal affective disorder (SAD), winter can be ...

Attention deficit hyperactivity disorder, or ADHD, is a long-term neurodevelopmental disorder usually found and diagnosed in ...

Magstim announced today that the FDA cleared its magnetic stimulation technology for the treatment of chronic pain.

Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and remember that hormones aren’t the only options for treating menopausal ...

Among the many mushrooms studied, Hericium erinaceus —better known as Lion’s Mane—stands out as a frontrunner in the quest to enhance brain health naturally. This white, shaggy mushroom contains two ...